Corrs Chambers Westgarth

Mining contractor BUMA, which was hired to provide services at the Commodore coal mine in Queensland, has come out on top in a $30 million dispute with the mine's owner, Genuity.

A banking and finance partner has joined Norton Rose Fulbright's Melbourne office after 15 years at Corrs Chambers Westgarth.

Gaming company Light & Wonder will pay $190 million to settle Aristocrat’s litigation in Australia and the United States alleging it misappropriated trade secrets in developing two poker machines.

The University of NSW has been hit with a $211,200 penalty after admitting to "systemic" underpayments of casual staff at its business school.

Otsuka Pharmaceuticals has asked the High Court to overturn a decision revoking its Abilify patent extension, saying the ruling, which limited the extension-of term scheme to active substances only, will “lead to a groundswell of court proceedings”.

German drug maker Merck KGaA is fighting US drug company Merck Sharp & Dohme over the alleged use of the ‘Merck’ mark in Australia, five years after their intellectual property spat was settled. 

Orders proposed by Apple after a judge’s finding that the digital giant and rival Google engaged in anti-competitive conduct would “rob the court’s findings of their detail, their efficacy and their bite”, Epic Games has said.

A community group has lost a legal challenge to a 50-60 km underground pipeline that will connect Santos’ $3.6 billion Narrabri gas project to the Hunter gas pipeline. 

An expert will not be asked to determine a potential cross-claim by Downer EDI Rail in a dispute with John Holland over a rollingstock manufacturing facility being constructed in Torbanlea.

The Full Federal Court has upheld a decision revoking Otsuka Pharmaceuticals’ patent extension for an injectable version of antipsychotic drug Abilify, finding the patent expired last year.